No.
Thalidomide is banned in the US for administration to pregnant women, true. It is currently used in the US to treat leprosy and multiple myeloma, and number of off-label uses, all of which are serious or life-threatening medical conditions. It could be administered as an antinausea drug, I suppose, but why bother when Zofran is far cheaper and less problematic?
You can write the editors of Clinical Pharmacology and tell them they’re wrong, but I don’t think they’ll be very keen.
However, some of you are correct in stating that there are other cancer fighting qualities in Thalidomide as well.
“Unlabeled Uses
Graft versus host disease after bone marrow transplantation; refractory multiple myeloma; primary brain tumors; appetite stimulant for cachexia in advanced cancer; aphthous ulcers; prostate cancer (in combination with docetaxel).”